Header Logo

Connection

Karen Wernli to Breast

Back to Details
This is a "connection" page, showing publications Karen Wernli has written about Breast.
Karen Wernli
Connection Strength
2.552
Breast
  1. Change in Breast Cancer Screening Intervals Since the 2009 USPSTF Guideline. J Womens Health (Larchmt). 2017 08; 26(8):820-827.
    View in: PubMed
    Score: 0.546
  2. Patterns of breast magnetic resonance imaging use in community practice. JAMA Intern Med. 2014 Jan; 174(1):125-32.
    View in: PubMed
    Score: 0.440
  3. Investigation of mammographic breast density as a risk factor for ovarian cancer. J Natl Cancer Inst. 2014 Jan; 106(1):djt341.
    View in: PubMed
    Score: 0.438
  4. Prior breast density awareness, knowledge, and communication in a health system-embedded behavioral intervention trial. Cancer. 2020 04 15; 126(8):1614-1621.
    View in: PubMed
    Score: 0.168
  5. Surveillance Breast MRI and Mammography: Comparison in Women with a Personal History of Breast Cancer. Radiology. 2019 08; 292(2):311-318.
    View in: PubMed
    Score: 0.160
  6. Preoperative breast MRI and mortality in older women with breast cancer. Breast Cancer Res Treat. 2018 Jul; 170(1):149-157.
    View in: PubMed
    Score: 0.147
  7. Underutilization of Supplemental Magnetic Resonance Imaging Screening Among Patients at High Breast Cancer Risk. J Womens Health (Larchmt). 2018 06; 27(6):748-754.
    View in: PubMed
    Score: 0.146
  8. Relationship between preoperative breast MRI and surgical treatment of non-metastatic breast cancer. J Surg Oncol. 2017 Dec; 116(8):1008-1015.
    View in: PubMed
    Score: 0.144
  9. Disparities in the use of screening magnetic resonance imaging of the breast in community practice by race, ethnicity, and socioeconomic status. Cancer. 2016 Feb 15; 122(4):611-7.
    View in: PubMed
    Score: 0.126
  10. Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapy. JAMA Intern Med. 2013 May 13; 173(9):807-16.
    View in: PubMed
    Score: 0.105
  11. Reassessing the Benefits and Harms of Risk-Reducing Medication Considering the Persistent Risk of Breast Cancer Mortality in Estrogen Receptor-Positive Breast Cancer. J Clin Oncol. 2023 Feb 01; 41(4):859-870.
    View in: PubMed
    Score: 0.051
  12. Assessment of a Risk-Based Approach for Triaging Mammography Examinations During Periods of Reduced Capacity. JAMA Netw Open. 2021 03 01; 4(3):e211974.
    View in: PubMed
    Score: 0.045
  13. Performance Benchmarks for Screening Breast MR Imaging in Community Practice. Radiology. 2017 10; 285(1):44-52.
    View in: PubMed
    Score: 0.035

© 2024 Kaiser Permanente